Inactive Instrument

CuraGen Corporation Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

31/09/31	CURAGEN CO USD0.01 : CuraGen Reports Second Quarter 2009 Financial Results	PR
30/-1/30	CURAGEN : Reports Third Quarter 2008 Financial Results	PR
30/-1/30	CURAGEN : to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008	PR
30/-1/30	CURAGEN : Corporation Receives Notification from NASDAQ	PR
30/-1/30	CURAGEN : Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	-0.33%	+1.83%	+23.03%	-6.22%	6.88TCr
UCB	+0.67%	+0.93%	+37.53%	+198.53%	5.21TCr
SAMSUNG BIOLOGICS CO.,LTD.	+0.94%	+39.60%	+39.60%	+39.60%	4.35TCr
CSL LIMITED	+1.12%	+0.35%	-50.35%	-52.35%	4.12TCr
BIOGEN INC.	-1.40%	+3.43%	+60.07%	-26.01%	3.04TCr
MODERNA, INC.	-2.11%	-9.45%	+91.99%	-49.58%	2.45TCr
INCYTE CORPORATION	+0.51%	+0.46%	+70.08%	+91.96%	2.34TCr
INNOVENT BIOLOGICS, INC.	-5.57%	-0.84%	-0.17%	+174.11%	1.98TCr
SWEDISH ORPHAN BIOVITRUM AB	-0.86%	-1.99%	+68.42%	+124.39%	1.66TCr
Average	-0.78%	-0.81%	+37.80%	+54.94%	3.56TCr
Weighted average by Cap.	-0.34%	-0.07%	+31.34%	+47.23%

Employees

Sector